Pharmaceutical Manufacturing of Doxycycline Hyclate Tablets

The contract pertains to the manufacture of eight bottles of Doxycycline Hyclate Tablets, USP, each containing 100 mg per tablet, with all production requiring strict adherence to FDA, USP, and DLA quality standards to ensure safety, consistency, and regulatory compliance. The work is categorized as a subcontract under NAICS code 325412, and the place of performance is designated as Fort Bragg with a ZIP code of 28310, indicating delivery must align with Department of Defense logistics protocols. The solicitation was posted on July 15, 2026, with responses due by July 21, 2026, providing a narrow six-day window for submission. The contracting entity is the Medical Supply Chain Pharm FSA under the Department of Defense, emphasizing the military nature of the procurement and the critical role of timely supply delivery for operational medical needs.